Jim Simons Point Biopharma Global Inc. Transaction History

Renaissance Technologies LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$6.67 - $9.71 $909,094 - $1.32 Million	136,296 Added 71.37%	327,271 $2.18 Million
Q2 2023 Aug 11, 2023	SELL	$6.86 - $10.86 $690,973 - $1.09 Million	-100,725 Reduced 34.53%	190,975 $1.73 Million
Q1 2023 May 12, 2023	BUY	$6.78 - $8.1 $1.82 Million - $2.17 Million	268,000 Added 1130.8%	291,700 $2.12 Million
Q4 2022 Feb 13, 2023	SELL	$5.72 - $9.78 $91,520 - $156,480	-16,000 Reduced 40.3%	23,700 $173,000
Q3 2022 Nov 14, 2022	BUY	$7.24 - $10.31 $287,428 - $409,307	39,700 New	39,700 $307,000

20K

Ticker PNT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 104,025,000
Description
POINT Biopharma Global Inc., a radiopharmaceutical company, focuses on the development and commercialization of radioligands that fight cancer. Its lead product candidates include PNT2002, a prostate-specific membrane antigen (PSMA) targeted radioligand that is in Phase III trial for the treatment of metastatic castration-resistant prostate canc...

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.